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The b-galactosidase reporter gene, either free or com-
plexed with various cationic vectors, was microinjected
into mammalian cells. Cationic lipids but not polyethyl-
enimine or polylysine prevent transgene expression
when complexes are injected in the nucleus. Polyethyl-
enimine and to a lesser extent polylysine, but not cati-
onic lipids, enhance transgene expression when com-
plexes are injected into the cytoplasm. This latter effect
was independent of the polymer vector/cDNA ionic
charge ratio, suggesting that nucleic acid compaction
rather than surface charge was critical for efficient nu-
clear trafficking. Cell division was not required for nu-
clear entry. Finally, comparative transfection and mi-
croinjection experiments with various cell lines confirm
that barriers to gene transfer vary with cell type. We
conclude that polymers but not cationic lipids promote
gene delivery from the cytoplasm to the nucleus and
that transgene expression in the nucleus is prevented by
complexation with cationic lipids but not with cationic
polymers.
Despite their low efficiency in comparison to viral vectors
(1–3), cationic vectors retain high attractiveness in gene ther-
apy due to their theoretically excellent safety profile. Many
research efforts are currently dedicated to optimizing transfec-
tion efficiency of nonviral vectors, and in this context, several
novel chemical entities have recently being disclosed (4–6).
However, rational (as opposed to empirical) chemical design of
improved vectors requires a better knowledge of the multistage
process by which nonviral vectors promote transgene expres-
sion in eucaryotic cells. Initial interaction of the synthetic
vector with cDNA to form a complex (7–9) as well as delivery of
the complex into the cell via an endocytosis pathway (9–13)
have been studied in detail. By comparison, much less is known
about intracellular trafficking of the transgene to the nucleus
where it is transcribed. Release of cDNA from the endosomes is
suggested to proceed by destabilization of the endosomal mem-
brane (14). Zabner et al. (9) postulated that the cDNA must
then dissociate from the cationic lipid vector before naked
cDNA enters the nucleus. To this end, anionic lipids normally
found on the cytoplasmic-facing monolayer of cell membrane
can very potently displace cDNA from the cationic
liposomezcDNA complex (14).
In this report, we demonstrate that synthetic polymers such
as polyethylenimine (4, 15) and polylysine differ from cationic
lipids inasmuch as (i) polymers promote gene delivery from the
cytoplasm to the nucleus and (ii) transgene expression in the
nucleus is prevented by complexation with cationic lipids but
not with cationic polymers. Our findings provide new rationale
for future developments targeted to improve the efficiency of
nonviral vectors and highlight the in vitro superiority of cati-
onic polymer vectors over cationic lipids.
EXPERIMENTAL PROCEDURES
Zeta Potential Measurements—Polyethylenimine (PEI)/DNA1 zeta
potential was determined using a Zetamaster 3000 (Malvern Instru-
ment, Orsay, France) with the following specifications: sampling time,
30 s; three measurements per sample; viscosity, 1.014 centipoise; di-
electric constant, 79; temperature, 20 °C.
Electron Microscopy—Carbon films were prepared by sublimation on
freshly cleaved mica and recovered by flotation on Cu21/Rh21 grids (300
mesh, Touzard & Matignon, Courtaboeuf, France). After overnight dry-
ing, grids were kept on a blotting paper in a Petri dish. Immediately
before sample addition, grids were glow-discharged (110 mV, 25 s). A
drop (5 ml) of sample solution was left on the grid for 1 min. Complexes
were negatively stained with 30 ml of aqueous uranylacetate (1% w/w)
for 20 s, and excess liquid was removed with blotting paper. Observa-
tions were performed at 80 kV with a Philips EM 410 transmission
electron microscope.
Cell Cultures—COS-7 cells, pancreatic epithelioid CFPAC-1 from a
DF5808/DF508 cystic fibrosis patient and human A549 lung carcinoma
cells obtained from the ATCC (Rockville, MD) were cultured as previ-
ously indicated (16).
Polycations and Plasmids—PEI (25 kDa) and polylysine were used
as 10 mM monomer aqueous stock solution. Dioctadecylamidoglycyl
spermine (Transfectam®, Promega, Madison, WI) was used as a 2 mM
ethanolic solution. N-(1-(2,3-dioleolyloxy)propyl)-N,N,N-trimethylam-
monium methylsulfate (DOTAP, Boehringer Mannheim) was used in
aqueous solution at 1 mg/ml. A pCMV-LacZ plasmid in which the
b-galactosidase cDNA was established under the control of the CMV
promoter was used as a reporter gene. Alternatively, we used a pCMV-
cystic fibrosis transmembrane conductance regulator (CFTR) plasmid
(a kind gift from J. Ricardo, Lisbon, Portugal) in which a CMV promoter
drove expression of the CFTR protein.
Cell Transfection—Adherent cells were seeded in 24-well plates (Life
Technologies, Inc.). Amounts and volumes given below refer to a single
well. Two mg pf pCMV-LacZ were diluted into 50 ml of a 150 mM NaCl
solution. The desired amount of 25-kDa PEI was diluted into 50 ml of
150 mM NaCl, gently vortexed, spun down (500 rpm for 5 s), and then
incubated for 10 min. PEI was used at PEI/cDNA ratios between 2 and
10 equivalents (PEI/cDNA ratio calculated on the basis of PEI
nitrogen/cDNA phosphate; see Ref. 15). The cationic vector was added
to the plasmid solution, mixed, vortexed, spun down, and incubated for
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10 min. Twenty-four h post-transfection, cells were fixed for 15 min
with 0.5% formaldehyde and then analyzed histochemically using X-gal
(17). All experiments were done in duplicate.
Intracellular Plasmid Microinjections—Cells were microinjected at
day 1 post-plating. In this procedure, we used the Eppendorf microin-
jector 5246 system, the micromanipulator 5171 system, and a Nikon
Diaphot inverted microscope. Nuclear or intracytoplasmic injections
were performed with the Z (depth) limit option using a 0.3-s injection
time and 30–80-hectopascal injection pressure. Injection pipettes (in-
ternal diameter 0.5 6 0.2 mm) were pulled from borosilicate glass
capillaries. Plasmids were diluted at a final concentration ranging from
0.01 to 100 mg/ml in an injection buffer made of 50 mM HEPES, 50 mM
NaOH, 40 mM NaCl, pH 7.4. 0.5% fluorescein isothiocyanate-dextran
(150 kDa) was added to the injection medium. The plasmid solution was
injected into the cells, and the exact number of nuclearly or cytoplas-
mically injected cells was counted. Twenty-four h post-injection, cells
were fixed and analyzed for exogenous b-galactosidase expression. Di-
octadecylamidoglycyl spermine was used at six charge equivalents (six
cationic amino groups per phosphate group). For polylysine, we used 0.6
ml of polylysine 10 mM/mg of plasmid. This mixture yields a
polylysine/cDNA ratio of 2, corresponding to a PEI/cDNA ratio of 5 on
the basis of the ionic charges of the complexes. In a separate set of
experiments, we observed that polylysine transfection efficacy peaked
at 2 equivalents.2 For DOTAP, we used 6 ml of DOTAP/mg of plasmid.
Determination of Injected Volume—The volume of the solution intra-
cellularly microinjected was determined using radiolabeled probes.
0.5% fluorescein isothiocyanate-dextran supplemented with 99Tc (80
mCi/ml) or 111In (50 mCi/ml) was injected into the nucleus of 100 cells.
Immediately after injection, cells were washed in phosphate-buffered
saline containing 137 mM NaCl, 2.7 mM KCl, 8 mM Na2HPO4, 1.5 mM
KH2PO4, 1 mM CaCl2, 1 mM MgCl2, pH 7.4. Cells were trypsinized and
suspended into 1.5 ml of culture medium, and the radioactivity of the
solution in cpm was determined. Different solutions of known volumes
and radioactive concentrations were used as internal standards. In
COS-7 cells, 8735 6 823 cpm/ml was measured in the cell lysate (n 5
four experiments) using 99Tc. This value corresponded to an estimated
injection volume of 923 6 191 fl/cell (range: 587 to 1402 fl/cell). A
comparable estimate was also obtained using 111In. Thus, for a pCMV-
LacZ plasmid concentration of 100 mg/ml, the number of injected cDNA
copies was in the order of 10,000/cell. This value is 1 log lower than the
number of cDNA copies entering a cell during transfection with PEI, as
evaluated with electronic microscopy imaging (18). The large variability
we observed in injection volume estimate is consistent with previous
reports (19).
6-Methoxy-1-(3-sulfonatopropyl) quinolinium (SPQ) Fluorescence As-
say—Our method has been reported in detail elsewhere (16). Cells
placed on glass coverslips were loaded with the intracellular dye SPQ
(Molecular Probes) by incubation in hypotonic (50% dilution) medium.
The coverslip was mounted on the stage of a Nikon Diaphot inverted
microscope equipped for fluorescence and illuminated at 370 nm. The
emitted light was collected by a high resolution image intensifier cou-
pled to a video camera (Extended ISIS camera system, Photonic Sci-
ence) connected to a digital image processing board controlled by FLUO
software (Imstar, Paris, France). To standardize the fluorescence re-
sponse to solution changes, the initial fluorescence level in the presence
of I2 was taken as zero. The control Tyrode’s solution for SPQ experi-
ments contained 145 mM NaCl, 4 mM KCl, 1 mM MgCl2, 1 mM CaCl2, 5
mM HEPES, 5 mM glucose, and 10 mM bumetanide, and the pH was
adjusted to 7.4 with NaOH. I2 and NO3
2 media were identical to the
control Tyrode solution except that I2 or NO32 replaced Cl2 as the
dominant extracellular anion.
RESULTS
Efficiency of cDNA Injection in COS-7 Cells—pCMV-LacZ
plasmids complexed or not with PEI were microinjected into
COS-7 cells, which were analyzed for exogenous b-galactosid-
ase expression 24 h post-injection. Control experiments dem-
onstrated that nuclear or cytoplasmic injection with naked
cDNA or with PEIzcDNA complexes was not associated with
cell toxicity. As illustrated in Fig. 1A, epifluorescence micros-
copy discriminated cells that were correctly injected into the
nucleus from those injected into the cytoplasm. The efficiency
of our injection procedure was defined as the ratio between the
number of cells per Petri dish exhibiting X-gal blue staining
(Fig. 1B) divided by the number of injected cells exhibiting
fluorescein isothiocyanate-dextran fluorescence. Fig. 2A sum-
marizes data obtained after intranuclear injection and shows
that the injection efficiency increased according to a sigmoidal
relation as the number of injected cDNA copies increased in the
range 1021–104 copies/cell. Fig. 2A, (right panel) shows that
transgene expression was comparable in the absence or pres-
ence of PEI, irrespective of the PEI/cDNA ratio used, i.e. of the
ionic charge of the PEIzcDNA complexes. Data obtained with
intracytoplasmic microinjections are summarized on Fig. 2B.
As previously reported (20–22), intracytoplasmic injection of
naked cDNA led to a low expression of the reporter gene (,15%
of the cells), yet only at injected cDNA copies/cell greater than
103 (Fig. 2B). Remarkably, cDNA complexation with PEI in-
creased transgene expression (Fig. 2B). Comparable expres-
sions (40–50%) were observed after injection of 104 copies in
the cytoplasm and 102 copies in the nucleus. Increased expres-
sion when cDNA was complexed with PEI was noticed only for
PEI/DNA ratio higher or equal to 2 (Fig. 2B) and may be a
consequence of the electrostatic charge and/or of the morphol-
ogy of the complexed DNA. Zeta potential (an indication of
surface charge) measurements of PEIzcDNA complexes per-
formed with increasing amounts of PEI showed that particles
become neutral at a PEI/cDNA ratio around 3.5. The morphol-
ogy of PEIzcDNA complexes may be inferred from a combina-
tion of centrifugation and electron microscopy experiments.
Complexes formed at a PEI/cDNA ratio of 1 cannot be pelleted
(,5%, 10 min, 11,000 3 g), presumably because of extensive
DNA looping out (Fig. 3), whereas for PEI/DNA ratio 2–10,
complexes were compact and centrifugable (.80%). We next
explored whether in cytoplasmic injection experiments, the
reporter gene was necessarily reaching the nucleus at the time
of cell division. To this goal, isolated cells (,10% confluency)
were injected in the cytoplasm with pCMV-LacZ (104 cDNA
copies/cell) complexed with 5 equivalents of PEI (n 5 4 assays;
107 cells). If plasmid cDNA only had access to the nucleus
during the transient breakdown of the nuclear membrane that
is associated with mitosis, then one would expect to see only
clusters of at least 2 cells expressing the transgene. We ob-
served that 20 cells out of 40 expressing the transgene were
isolated cells (Fig. 4), indicating that cell mitosis was not an
absolute requirement for transgene expression.2 J.-S. Remy, unpublished observations.
FIG. 1. A, fluorescence microscopy of COS-7 cells after intranuclear
(left) or intracytoplasmic injections (right) with fluorescein isothiocya-
nate-dextran containing solution. B, fluorescence microscopy and X-gal
staining in the same cells intranuclearly injected with pCMV-LacZ
(injected cDNA copies, 10,000/cell).
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Expression Kinetics in Transfected and in Injected Cells—
COS-7 were transfected with pCMV-LacZ complexed with PEI.
Eight h post-transfection, a low percentage of cells showed
b-galactosidase activity (Fig. 5, left panel). At 12 and 24 h
post-transfection, '20 and 60% of the cells expressed the trans-
gene, respectively. By contrast, 4 h post-injection of naked or
complexed cDNA into the nucleus, a high percentage of cells
already expressed the transgene. In cells injected into the
cytoplasm with naked cDNA, at least 12 h of incubation were
needed to detect transgene expression. Eight h post-injection in
the cytoplasm of PEIzcDNA complexes, a detectable proportion
of cells stained blue. Prolonging the incubation period from 24
to 48 h only slightly increased expression efficiency. Expression
kinetics were also followed using a pCMV-CFTR plasmid and a
SPQ fluorescence assay. Measurements of membrane perme-
ability to halide under cAMP stimulation was used to detect
functional CFTR proteins in relation to post-injection time (Fig.
5, right panel). Direct intranuclear PEI/cDNA injection in
COS-7 cells led to the expression of a CFTR-related conduct-
ance within 4 h, i.e. within the same time frame as b-galacto-
sidase expression. Comparable kinetics were observed with
nuclear injection of naked cDNA. Microinjection of PEIzpCMV-
CFTR in the cytoplasm markedly delayed transgene expression
in comparison to nuclear injections, with detectable transgene
expression 12 h post-injection. We concluded that (i) exogene
transcription and translation are fast processes and (ii) trans-
gene expression kinetics after intracytoplasmic injection and
transfection were comparable, pointing at plasmid intracellu-
lar trafficking to the nucleus as the rate-limiting step.
Transfection and Injection Efficiencies in COS-7, CFPAC-1,
and A549 Epithelial Cell Lines—Transfection efficiency was
markedly variable between different cell lines, since it was
much greater in COS-7 than in CFPAC-1 or A549 cells (Fig.
6A). Consistent with previous studies using PEI (4), transfec-
tion efficiency was optimal at a PEI/cDNA ratio of at least 5
equivalents, i.e. when complexes were positively charged. Nu-
clear injection of cDNAzPEI led to comparable expression for all
cells (Fig. 6B), suggesting similar transcription levels. By con-
trast, the efficiency after cytoplasmic injections markedly var-
ied with the cell line, with the highest efficiency in COS-7 cells
and the lowest in A549 cells.
Expression Efficiency after Injection with Various Cationic
Vectors—Finally, we investigated the influence of the vector’s
molecular nature on transgene expression. In agreement with
previous reports (9, 22), neither cytoplasmic nor nuclear injec-
tion of cDNA complexed with cationic lipids such as dioctade-
cylamidoglycyl spermine or DOTAP produced blue stained cells
(Fig. 7). By contrast, nuclear and cytoplasmic injections of
cDNA complexed with polylysine produced consistent expres-
sion of the reporter gene albeit with a lower efficacy than with
PEI (p , 0.001 in both cases).
DISCUSSION
Our results demonstrate that cDNA complexation with cat-
ionic polymers promotes gene accessibility to the nucleus, a
property that is not observed with cationic lipids. When 10,000
naked cDNA copies were injected in the cytoplasm, only 13% of
the cells expressed the transgene. A comparable expression
efficiency was obtained when less than 10 copies of naked
cDNA were directly injected into the nucleus. This suggests
that less than 1/1000 naked cDNA copies injected in the cyto-
plasm were effectively trafficked to the nucleus, an estimate
that is in agreement with previous observations (9, 18). A
similar calculation shows that 1/100 cDNAzPEI complexes were
FIG. 2. Efficiency of intranuclear (A) and cytoplasmic (B)
cDNA microinjections in COS-7 cells. In A and B (left panels)
dose-effect relations with naked pCMV-LacZ cDNA (open symbols) or
with PEIzcDNA complexes at 5 equivalents (filled symbols) are shown.
A variable number of injected plasmid copies as indicated on the x axis
was used. Data are mean 6 S.E., with n between 178 and 650. Right
panels show the effects of varying the PEI/cDNA ratio on injection
efficiency. Cells were injected with 10,000 plasmid copies. Stars indi-
cate significant difference, with p , 0.05 (*) or p , 0.001 (***) between
cells injected with naked DNA and cells injected with DNA complexed
with PEI.
FIG. 3. Electron micrographs of PEIzDNA complexes. Particles
prepared at 1 equivalent of PEI (a and b) show incomplete DNA con-
densation, with nucleic acid looping out of the particle core. Higher
input of PEI (10 equivalents (c)) allows the formation of an homogenous
population of spherical complexes.
FIG. 4. Light microscopy of an isolated COS-7 cell after intra-
cytoplasmic injection of PEIzpCMV-LacZ complexes at 5 equiv-
alents. X-gal staining.
Polyethylenimine Promotes Transgene Delivery 7509
trafficked to the nucleus and thus that cDNA complexation
increased 10-fold the access of the transgene to the nucleus.
Our results also show that in opposition to cationic lipids,
cationic polymers when injected in the nucleus do not prevent
gene expression and thus likely disassemble from cDNA in the
nucleus, a process that is supposedly fast since expression
kinetics were very similar with coated or uncoated cDNA. We
have also showed that rupture of the nuclear envelope as oc-
curs during cell division was not an absolute requirement for
penetration of cDNAzPEI complexes into the nucleus. This ob-
servation is in agreement with efficient in vitro (23) and in vivo
(24) PEI-mediated transfections of post-mitotic cells such as
neurons. In addition, we found that compaction of plasmid
cDNA into spherical particles rather than the ionic strength of
the cDNAzPEI complexes appeared as a critical factor for trans-
gene trafficking to the nucleus. Finally, expression kinetics
after intracytoplasmic injection of cDNAzPEI complexes or clas-
sical PEI-mediated cell transfection were comparable, suggest-
ing trafficking through the nuclear envelope as the rate-limit-
ing step. The simplest explanation to account for our results as
a whole is that plasmids coated with polymers but not with
cationic lipids are targeted to the nucleus. However, alterna-
tive mechanisms could also very well explain our observations,
including improved intracytoplasmic mobility or polymer-re-
lated protection of cDNA from endogenous nuclease degrada-
tion. Current programs in our laboratory are dedicated to eval-
uating this latter hypothesis. Transfection efficiency with PEI
markedly varied depending on the cell line, with low levels of
expression in CFPAC-1 or A549 epithelial cells. Intracytoplas-
mic injection of cDNAzPEI complexes in CFPAC-1 and in A549
cells led a lower level of expression as compared with COS-7
cells, although this did not reach significance in CFPAC-1 cells.
These results suggest that intracellular barriers to plasmid
trafficking quantitatively varies with cell type.
Nuclear transport in mammalian cells is a critical limiting
step in gene transfer using nonviral vectors (9, 18). Our data
are in line with a reasonable scheme proposed by Xu and Szoka
FIG. 7. Percentage of X-gal-positive cells after injection of
cDNA pCMV-LacZ plasmid complexed with different vectors.
Intranuclear (filled bars) or intracytoplasmic (empty bars) injections of
COS-7 cells were performed with pCMV-LacZ (copy number: 10,000/
cell) complexed with 5 equivalents of PEI or 6 equivalents of dioctade-
cylamidoglycyl spermine. Polylysine and DOTAP were complexed to the
plasmid as described under “Experimental Procedures.” Data are
mean 6 S.E. n, the number of injected cell per experimental condition,
varied from 325 to 470. DOGS, dioctadecyl amido glycyl spermine.
FIG. 5. Transgene expression kinetics after transfection or microinjection in COS-7 cells. In the left panel, COS-7 cells were either
injected into the nucleus (circles) or the cytoplasm (triangles) with naked pCMV-LacZ cDNA (injected cDNA copies, 10,000 per cell (open symbols))
or with pCMV-LacZ complexed with 5 equivalents of PEI (filled symbols) or transfected with pCMV-LacZ (2 mg) complexed with 5 equivalents of
PEI (crossed symbols). After various durations of incubation as indicated on the x axis, cells were revealed for b-galactosidase activity and counted.
* denotes p , 0.05; ** p , 0.01; and *** p , 0.001 versus cells injected with naked cDNA. E, nuclear naked; l, nuclear PEI; v, transfected; ,
cytoplasm naked; , cytoplasm PEI. The right panel shows pCMV-CFTR expression kinetics after direct microinjection of pCMV-CFTR in COS-7
cells assayed with SPQ fluorescence microscopy. The rate of SPQ dequenching under nitrate application in the presence of forskolin (10 mM), which
reflects the cell permeability to halide upon cAMP stimulation, is plotted against time elapsed after nuclear or cytoplasmic injections with
pCMV-CFTR complexed with PEI (filled symbols) or nuclear injections with naked pCMV-CFTR (open circles). *** denotes p , 0.001 versus cells
injected in the cytoplasm with cDNAzPEI complexes. Injected copy number: 10,000 in all cases. Data are mean 6 S.E. of 6–12 different cells.
FIG. 6. Transfection and injection
efficiencies in COS-7 (black bars),
CFPAC-1 (gray bars), or A549 cells
(empty bars). A, cells were transfected
with pCMV-LacZ complexed with PEI at
variable equivalents. B, comparison of in-
jection efficiencies in different cell lines
after intranuclear or intracytoplasmic in-
jections of cDNAzPEI complexes at 5
equivalents. Injected copy number:
10,000 in all cases. ** denotes p , 0.01
versus intracytoplasmically injected
COS-7 cells.
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(14) postulating that during transfection, cDNA is released
from cationic lipids in the cytoplasm and is then trafficked
uncoated by an inefficient mechanism into the nucleus. The
present work suggests that the sequence leading to transfec-
tion with cationic polymers differs from the latter scheme in-
asmuch as coated cDNA may penetrate post-mitotic nuclei
where it is most likely released by competitive interaction with
genomic DNA (25). Our data also suggest that cDNA compac-
tion rather than the ionic charge of cDNA complexes improves
nuclear targeting. Altogether these findings provide a novel
mechanistic basis for rational vector design.
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